RESUMO
Biocompatible quercetin nanovesicles were developed by coating polyethylene glycol-containing vesicles with chitosan and nutriose, aimed at targeting the colon. Uncoated and coated vesicles were prepared using hydrogenated soy phosphatidylcholine and quercetin, a potent natural anti-inflammatory and antioxidant drug. Physicochemical characterization was carried out by light scattering, cryogenic microscopy and X-ray scattering, the results showing that vesicles were predominantly multilamellar and around 130 nm in size. The in vitro release of quercetin was investigated under different pH conditions simulating the environment of the gastrointestinal tract, and confirmed that the chitosan/nutriose coating improved the gastric resistance of vesicles, making them a potential carrier system for colon delivery. The preferential localization of fluorescent vesicles in the intestine was demonstrated using the In Vivo FX PRO Imaging System. Above all, a marked amelioration of symptoms of 2,4,6-trinitrobenzenesulfonic acid-induced colitis was observed in animals treated with quercetin-loaded coated vesicles, favoring the restoration of physiological conditions. Therefore, quercetin-loaded chitosan/nutriose-coated vesicles can represent a valuable therapeutic tool for the treatment of chronic intestinal inflammatory diseases, and presumably a preventive system, due to the synergic action of antioxidant quercetin and beneficial prebiotic effects of the chitosan/nutriose complex.
Assuntos
Antioxidantes , Materiais Revestidos Biocompatíveis , Colite , Portadores de Fármacos , Nanopartículas/química , Quercetina/análogos & derivados , Animais , Antioxidantes/química , Antioxidantes/farmacologia , Quitosana/química , Quitosana/farmacologia , Colite/congênito , Colite/tratamento farmacológico , Colite/enzimologia , Colite/patologia , Portadores de Fármacos/química , Portadores de Fármacos/farmacologia , Masculino , Quercetina/química , Quercetina/farmacologia , Ratos , Ratos Wistar , Ácido Trinitrobenzenossulfônico/toxicidadeRESUMO
Few cases of severe postnatally acquired cytomegalovirus (CMV) infection are reported in premature infants. We report on an extremely low birthweight (ELBW) preterm infant who presented with a sepsis-like syndrome and multiple organ involvement, notably pneumonitis and colitis. The course of infection was assessed by repeated analysis of urine, tracheal aspirates and blood. The patient was given intravenous ganciclovir. The clinical course was rapidly favorable. Development of neutropenia led to the discontinuation of the antiviral treatment after 28 days. Follow-up showed moderate white matter anomalies on cerebral MRI, a transient hypoacusis and a mild developmental delay at 18 months of corrected age. To the best of our knowledge, this is the first description of a severe combination of pneumonitis and colitis in postnatal CMV infection. Many issues remain controversial and are discussed. We propose that antiviral treatment should be considered in severe postnatal CMV infection in ELBW patients.
Assuntos
Colite/complicações , Infecções por Citomegalovirus/complicações , Recém-Nascido de Peso Extremamente Baixo ao Nascer , Pneumonia/complicações , Síndrome de Resposta Inflamatória Sistêmica/complicações , Adulto , Colite/congênito , Infecções por Citomegalovirus/congênito , Feminino , Humanos , Lactente , Recém-Nascido , Pneumonia/congênito , Gravidez , Índice de Gravidade de Doença , Síndrome de Resposta Inflamatória Sistêmica/congênitoAssuntos
Doenças do Colo/virologia , Infecções por Citomegalovirus/congênito , Obstrução Intestinal/virologia , Colite/congênito , Colite/virologia , Doenças do Colo/congênito , Constrição Patológica/congênito , Constrição Patológica/virologia , Humanos , Recém-Nascido , Obstrução Intestinal/congênito , Masculino , Úlcera/congênito , Úlcera/virologiaRESUMO
The etiology of perceptive deafness, especially the congenital variety, requires investigation. The presence of a variety of signs associated with deafness constitutes an "associated syndrome" and helps to define a possible genetic origin. These syndromes only represent a small percentage of overall causes of deafness in children, since at most they account for only 10% of cases. Certain syndromes are encountered more often or are well known, others are extremely rare or have only been described recently. The authors report six of these very rare syndromes discovered among their patients: a KID syndrome, a Leopard syndrome, a Norrie syndrome, a Jervell and Lange Nielsen syndrome, a recently described entity called CEE with deafness and an External Neuro-Cochleo-Pancreatic syndrome which would not appear to have been previously described.